Condition
Ataxia, Gait
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Active Not Recruiting1
Recruiting1
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07427563Not ApplicableRecruitingPrimary
Cerebellar Deep Brain Stimulation for the Treatment of Ataxia
NCT07079332Not Yet Recruiting
Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS)
NCT05884086Active Not RecruitingPrimary
Ataxia GAA-FGF14 - Descriptive Genetic and Clinical Study
Showing all 3 trials